Timothy Wilens

Dr. Timothy Wilens discusses new ADHD medications and strategies for complex cases, including combination therapy. Topics include managing coexisting conditions, medication options, challenges in children, medication shortages impact, anxiety management, heart rate concerns, and OCD treatment strategies.

People with ADHD face an elevated risk for substance use disorder (SUD), and the stimulants that are prescribed for ADHD are also commonly misused. Timothy Wilens, M.D., discusses interventions for people with ADHD and a history of substance abuse.

Timothy E. Wilens, M.D., chief of Child and Adolescent Psychiatry at Mass General Hospital and a Harvard Medical School professor, dives into the complexities of diagnosing and treating ADHD in adolescents. He emphasizes the importance of early intervention and proper diagnosis to aid transitions into adulthood. The discussion covers treatment options, including medication and alternative therapies, and highlights tailored support for young people. Parents play a crucial role in balancing support and independence, especially regarding career guidance for their children.

Timothy Wilens, a Harvard psychiatrist and expert in ADHD and addiction medicine, cuts through myths about ADHD medications. He discusses why stigma persists, differences between stimulants and nonstimulants, diversion and misuse patterns, safety concerns, and how clinicians can counter misinformation. Multiple short, focused takes make complex evidence easy to follow.

Timothy E. Wilens, M.D., Chief of Child and Adolescent Psychiatry at Massachusetts General Hospital, shares insights on ADHD in teenagers. He discusses the impacts of delayed brain development and the associated risks of risky behavior. Wilens emphasizes the importance of scaffolding and structure for teens and challenges common misconceptions around medication use. He also covers how hormones affect ADHD and offers guidance on promoting academic achievement despite these hurdles.